Cargando…

Design and synthesis of a series of serine derivatives as small molecule inhibitors of the SARS coronavirus 3CL protease

Synthesis of serine derivatives having the essential functional groups for the inhibitor of SARS 3CL protease and evaluation of their inhibitory activities using SARS 3CL R188I mutant protease are described. The lead compounds, functionalized serine derivatives, were designed based on the tetrapepti...

Descripción completa

Detalles Bibliográficos
Autores principales: Konno, Hiroyuki, Wakabayashi, Masaki, Takanuma, Daiki, Saito, Yota, Akaji, Kenichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7111485/
https://www.ncbi.nlm.nih.gov/pubmed/26879854
http://dx.doi.org/10.1016/j.bmc.2016.01.052
_version_ 1783513300829470720
author Konno, Hiroyuki
Wakabayashi, Masaki
Takanuma, Daiki
Saito, Yota
Akaji, Kenichi
author_facet Konno, Hiroyuki
Wakabayashi, Masaki
Takanuma, Daiki
Saito, Yota
Akaji, Kenichi
author_sort Konno, Hiroyuki
collection PubMed
description Synthesis of serine derivatives having the essential functional groups for the inhibitor of SARS 3CL protease and evaluation of their inhibitory activities using SARS 3CL R188I mutant protease are described. The lead compounds, functionalized serine derivatives, were designed based on the tetrapeptide aldehyde and Bai’s cinnamoly inhibitor, and additionally performed with simulation on GOLD softwear. Structure activity relationship studies of the candidate compounds were given reasonable inhibitors ent-3 and ent-7k against SARS 3CL R188I mutant protease. These inhibitors showed protease selectivity and no cytotoxicity.
format Online
Article
Text
id pubmed-7111485
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-71114852020-04-02 Design and synthesis of a series of serine derivatives as small molecule inhibitors of the SARS coronavirus 3CL protease Konno, Hiroyuki Wakabayashi, Masaki Takanuma, Daiki Saito, Yota Akaji, Kenichi Bioorg Med Chem Article Synthesis of serine derivatives having the essential functional groups for the inhibitor of SARS 3CL protease and evaluation of their inhibitory activities using SARS 3CL R188I mutant protease are described. The lead compounds, functionalized serine derivatives, were designed based on the tetrapeptide aldehyde and Bai’s cinnamoly inhibitor, and additionally performed with simulation on GOLD softwear. Structure activity relationship studies of the candidate compounds were given reasonable inhibitors ent-3 and ent-7k against SARS 3CL R188I mutant protease. These inhibitors showed protease selectivity and no cytotoxicity. Elsevier Ltd. 2016-03-15 2016-01-29 /pmc/articles/PMC7111485/ /pubmed/26879854 http://dx.doi.org/10.1016/j.bmc.2016.01.052 Text en Copyright © 2016 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Konno, Hiroyuki
Wakabayashi, Masaki
Takanuma, Daiki
Saito, Yota
Akaji, Kenichi
Design and synthesis of a series of serine derivatives as small molecule inhibitors of the SARS coronavirus 3CL protease
title Design and synthesis of a series of serine derivatives as small molecule inhibitors of the SARS coronavirus 3CL protease
title_full Design and synthesis of a series of serine derivatives as small molecule inhibitors of the SARS coronavirus 3CL protease
title_fullStr Design and synthesis of a series of serine derivatives as small molecule inhibitors of the SARS coronavirus 3CL protease
title_full_unstemmed Design and synthesis of a series of serine derivatives as small molecule inhibitors of the SARS coronavirus 3CL protease
title_short Design and synthesis of a series of serine derivatives as small molecule inhibitors of the SARS coronavirus 3CL protease
title_sort design and synthesis of a series of serine derivatives as small molecule inhibitors of the sars coronavirus 3cl protease
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7111485/
https://www.ncbi.nlm.nih.gov/pubmed/26879854
http://dx.doi.org/10.1016/j.bmc.2016.01.052
work_keys_str_mv AT konnohiroyuki designandsynthesisofaseriesofserinederivativesassmallmoleculeinhibitorsofthesarscoronavirus3clprotease
AT wakabayashimasaki designandsynthesisofaseriesofserinederivativesassmallmoleculeinhibitorsofthesarscoronavirus3clprotease
AT takanumadaiki designandsynthesisofaseriesofserinederivativesassmallmoleculeinhibitorsofthesarscoronavirus3clprotease
AT saitoyota designandsynthesisofaseriesofserinederivativesassmallmoleculeinhibitorsofthesarscoronavirus3clprotease
AT akajikenichi designandsynthesisofaseriesofserinederivativesassmallmoleculeinhibitorsofthesarscoronavirus3clprotease